@article {1653582,
	title = {Acute Idiopathic Maculopathy Following SARS-CoV-2 Vaccination},
	journal = {Ocul Immunol Inflamm},
	volume = {31},
	number = {6},
	year = {2023},
	month = {2023 Aug},
	pages = {1232-1235},
	abstract = {A 49-year-old man presented with acute unilateral blurred vision one week after SARS-CoV-2 vaccination. A unilateral serous detachment of the macula, intraretinal hemorrhages, vitritis, and anterior chamber cell was found. Diagnostic testing was negative for infectious and inflammatory causes, and a diagnosis of acute idiopathic maculopathy (AIM) was made. Symptoms and serous detachment resolved over 12\&nbsp;weeks, with residual retinal pigment epithelial changes consistent with the disease course. AIM is a rare diagnosis that presented in close proximity to SARS-CoV-2 vaccination without evidence of coxsackievirus infection. Further research is necessary to clarify an association between this vaccine and uveitis.},
	keywords = {COVID-19, COVID-19 Vaccines, Fluorescein Angiography, Humans, Macular Degeneration, Male, Middle Aged, Retinal Diseases, SARS-CoV-2, Vaccination},
	issn = {1744-5078},
	doi = {10.1080/09273948.2022.2114915},
	author = {Bleicher, Isaac D and Brill, Daniel and Wu, Frances and Sobrin, Lucia and Patel, Nimesh}
}
